Electronic Health Record Alert With Heart Failure Risk and Sodium Glucose Cotransporter 2 Inhibitor Prescriptions in Diabetes: A Randomized Clinical Trial
In a single-center trial with low overall SGLT2i use, an EHR alert incorporating HF risk information significantly increased SGLT2i prescriptions and NP testing although the absolute rates were low.
Authors
- Matthew W. Segar (ORCID: https://orcid.org/0000-0001-6100-0897)
- DuWayne L. Willett (ORCID: https://orcid.org/0000-0002-3087-4193)
- Ambarish Pandey (ORCID: https://orcid.org/0000-0001-9651-3836)
- Kershaw V. Patel (ORCID: https://orcid.org/0009-0006-7418-4334)
- Neil Keshvani (ORCID: https://orcid.org/0000-0001-6890-8670)
- Vaishnavi Kannan (ORCID: https://orcid.org/0000-0002-3042-5427)
- David Charles Klonoff (ORCID: https://orcid.org/0000-0001-6394-6862)
Institutions
- Houston Methodist (US)
- Mills Peninsula Health Services (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1177/19322968241264747
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36